Highlights and Quick Summary
- Research and Development (R&D) Expenses Growth for the quarter ending March 31, 2023 was 20.46% (a -69.29% decrease compared to previous quarter)
- Year-over-year quarterly Research and Development (R&D) Expenses Growth decreased by -74.98%
- Annual Research and Development (R&D) Expenses Growth for 2022 was 0.0% (a -100.0% decrease from previous year)
- Annual Research and Development (R&D) Expenses Growth for 2022 was 82.49% (a 1034.66% increase from previous year)
- Annual Research and Development (R&D) Expenses Growth for 2021 was 7.27% (a -82.46% decrease from previous year)
- Twelve month Research and Development (R&D) Expenses Growth ending March 31, 2023 was 51.53% (a -37.53% decrease compared to previous quarter)
Trailing Research and Development (R&D) Expenses Growth for the last four month:
| 31 Mar '23 | 31 Dec '22 | — | — |
|---|---|---|---|
| 51.53% | 82.49% | — | — |
Visit stockrow.com/DRTS
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Research and Development (R&D) Expenses Growth of Alpha Tau Medical Ltd.
Most recent Research and Development (R&D) Expenses Growthof DRTS including historical data for past 10 years.Interactive Chart of Research and Development (R&D) Expenses Growth of Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd. Research and Development (R&D) Expenses Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | 20.46% | – | – | – | – |
| 2022 | 66.62% | 59.2% | 81.78% | 139.15% | 0.0% |
| 2021 | – | – | – | – | 7.27% |
| 2020 | – | – | – | – | 1.15% |
| 2019 | – | – | – | – | -12.04% |
Business Profile of Alpha Tau Medical Ltd.
Sector: Healthcare
Industry: Biotechnology